Li T - Search Results

1

Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.

Zhou Y, Zhou Y, Wang K, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Among authors: li t. Cancer Lett. 2020 Apr 1;474:94-105. doi: 10.1016/j.canlet.2020.01.010. Epub 2020 Jan 16. Cancer Lett. 2020. PMID: 31954771

2

HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.

Zhou Y, Wang K, Zhou Y, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Among authors: li t. Redox Biol. 2020 Jan;29:101390. doi: 10.1016/j.redox.2019.101390. Epub 2019 Nov 20. Redox Biol. 2020. PMID: 31785531 Free PMC article.

3

Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.

Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, Chen Y, Tan Y, Hu R. Li T, et al. Cancer Immunol Res. 2021 Sep;9(9):1008-1023. doi: 10.1158/2326-6066.CIR-20-1043. Epub 2021 Jul 20. Cancer Immunol Res. 2021. PMID: 34285037

4

Acquired temozolomide resistance in MGMT^low gliomas is associated with regulation of homologous recombination repair by ROCK2.

Zhang X, Li T, Yang M, Du Q, Wang R, Fu B, Tan Y, Cao M, Chen Y, Wang Q, Hu R. Zhang X, et al. Among authors: li t. Cell Death Dis. 2022 Feb 10;13(2):138. doi: 10.1038/s41419-022-04590-6. Cell Death Dis. 2022. PMID: 35145081 Free PMC article.

5

AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.

Zhang M, Jin C, Yang Y, Wang K, Zhou Y, Zhou Y, Wang R, Li T, Hu R. Zhang M, et al. Among authors: li t. J Cell Physiol. 2019 Nov;234(11):20161-20173. doi: 10.1002/jcp.28617. Epub 2019 Apr 5. J Cell Physiol. 2019. PMID: 30953357

6

Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.

Yang Y, Zhang M, Jin C, Ding Y, Yang M, Wang R, Zhou Y, Zhou Y, Li T, Wang K, Hu R. Yang Y, et al. Among authors: li t. J Cell Biochem. 2019 Oct;120(10):17744-17756. doi: 10.1002/jcb.29040. Epub 2019 Jun 18. J Cell Biochem. 2019. PMID: 31210372

7

Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.

Hu R, Li T, Hui K, Chen Z, Wang N, Wu X, Ge L, Zhou L. Hu R, et al. Among authors: li t. Mol Med Rep. 2020 Nov;22(5):3935-3943. doi: 10.3892/mmr.2020.11492. Epub 2020 Sep 7. Mol Med Rep. 2020. PMID: 32901884 Free PMC article.

8

ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.

Zhou Y, Zhou Y, Wang K, Li T, Zhang M, Yang Y, Wang R, Hu R. Zhou Y, et al. Among authors: li t. Cancers (Basel). 2019 Nov 27;11(12):1881. doi: 10.3390/cancers11121881. Cancers (Basel). 2019. PMID: 31783584 Free PMC article.

9

Fine particulate matter (PM_2.5): The culprit for chronic lung diseases in China.

Li T, Hu R, Chen Z, Li Q, Huang S, Zhu Z, Zhou LF. Li T, et al. Among authors: li q. Chronic Dis Transl Med. 2018 Aug 28;4(3):176-186. doi: 10.1016/j.cdtm.2018.07.002. eCollection 2018 Sep. Chronic Dis Transl Med. 2018. PMID: 30276364 Free PMC article.

10

A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways.

Dong Q, Yang B, Han JG, Zhang MM, Liu W, Zhang X, Yu HL, Liu ZG, Zhang SH, Li T, Wu DD, Ji XY, Duan SF. Dong Q, et al. Among authors: li t. Cancer Lett. 2019 Jul 28;455:60-72. doi: 10.1016/j.canlet.2019.04.031. Epub 2019 Apr 28. Cancer Lett. 2019. PMID: 31042588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,579 results

Search Page

Filters